Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery
- 25 December 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 78 (1-3) , 235-247
- https://doi.org/10.1016/s0168-3659(01)00505-3
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary ArteriesCirculation, 2001
- Nanoparticulate delivery system of a tyrphostin for the treatment of restenosisJournal of Controlled Release, 2000
- Acute Platelet Inhibition With Abciximab Does Not Reduce In-Stent Restenosis (ERASER Study)Circulation, 1999
- Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularizationThe American Journal of Cardiology, 1998
- The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteriesAdvanced Drug Delivery Reviews, 1997
- Nanoparticle drug delivery system for restenosisAdvanced Drug Delivery Reviews, 1997
- Local Irrigation With Tissue Factor Pathway Inhibitor Inhibits Intimal Hyperplasia Induced by Arterial InterventionsArchives of Surgery, 1996
- Local drug delivery for the prevention of restenosis. Fact, fancy, and future.Circulation, 1994
- Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial.Circulation, 1994
- Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis.Circulation, 1994